Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030
According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...
0 Комментарии 0 Поделились 18 Просмотры 0 предпросмотр
Спонсоры
Спонсоры
Спонсоры